Ariel Bulua Bourla (Ariel B Bourla, Rebecca A Miksad)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Metastatic Breast Cancer

Advance Care Planning

Top Venues

Advances in therapy

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Aracelis Z Torres, Nathan C Nussbaum, Christina M Parrinello, Ariel B Bourla, Bryan E Bowser, Samuel Wagner, David C Tabano, Daniel George, Ariel Bulua Bourla
Analysis of a Real-World Progression Variable and Related Endpoints for Patients with Five Different Cancer Types. Advances in therapy 39 (6) (2022)
Blythe J S Adamson, Xinran Ma, Sandra D Griffith, Elizabeth M Sweeney, Somnath Sarkar, Ariel Bulua Bourla
Differential frequency in imaging-based outcome measurement: Bias in real-world oncology comparative-effectiveness studies. Pharmacoepidemiology and drug safety (2021)
Ariel Bulua Bourla, Neal J Meropol
Bridging the divide between clinical research and clinical care in oncology: An integrated real-world evidence generation platform. Digital health 7 (2021)
Cynthia Huang Bartlett, Jack Mardekian, Matthew James Cotter, Xin Huang, Zhe Zhang, Christina M Parrinello, Ariel Bulua Bourla
Concordance of real-world versus conventional progression-free survival from a phase 3 trial of endocrine therapy as first-line treatment for metastatic breast cancer. PloS one 15 (4) (2020)